Hepatotoxins Stocks List

Related Stock Lists: Biopharmaceutical Medicine Analgesics Chemistry Drugs Fever Gilead Sciences Ibuprofen Infection Multiple Sclerosis Pain Paracetamol Pharmaceutical Tenofovir Disoproxil Acne AIDS Amines Antibiotic Antibiotics Bristol Myers Squibb

Recent Signals

Date Stock Signal Type
2020-07-07 ATXI Lower Bollinger Band Walk Weakness
2020-07-07 ATXI MACD Bearish Centerline Cross Bearish
2020-07-07 CPIX 20 DMA Resistance Bearish
2020-07-07 GILD Narrow Range Bar Range Contraction
2020-07-07 GILD Cup with Handle Other
2020-07-07 GILD NR7 Range Contraction
2020-07-07 GILD 50 DMA Support Bullish
2020-07-07 HEPA Parabolic Rise Strength
2020-07-07 HEPA Wide Range Bar Range Expansion
2020-07-07 HEPA Expansion Breakout Bullish Swing Setup
2020-07-07 HEPA Volume Surge Other
2020-07-07 HEPA Pocket Pivot Bullish Swing Setup
2020-07-07 HEPA Crossed Above 200 DMA Bullish
2020-07-07 PLXP Stochastic Buy Signal Bullish

Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage. Drug-induced liver injury is a cause of acute and chronic liver disease.
The liver plays a central role in transforming and clearing chemicals and is susceptible to the toxicity from these agents. Certain medicinal agents, when taken in overdoses and sometimes even when introduced within therapeutic ranges, may injure the organ. Other chemical agents, such as those used in laboratories and industries, natural chemicals (e.g., microcystins) and herbal remedies can also induce hepatotoxicity. Chemicals that cause liver injury are called hepatotoxins.
More than 900 drugs have been implicated in causing liver injury (see LiverTox, external link, below) and it is the most common reason for a drug to be withdrawn from the market. Hepatotoxicity and drug-induced liver injury also account for a substantial number of compound failures, highlighting the need for toxicity prediction models (e.g. DTI), and drug screening assays, such as stem cell-derived hepatocyte-like cells, that are capable of detecting toxicity early in the drug development process. Chemicals often cause subclinical injury to the liver, which manifests only as abnormal liver enzyme tests.
Drug-induced liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver failures.

More about Hepatotoxins